-
1
-
-
0026502510
-
Antiviral agents
-
M.R. Keating Antiviral agents Mayo Clin Proc 67 1992 160 178
-
(1992)
Mayo Clin Proc
, vol.67
, pp. 160-178
-
-
Keating, M.R.1
-
2
-
-
0037052352
-
Sexually transmitted diseases treatment guidelines 2002
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines 2002 MMWR Morb Mortal Wkly Rep 51 RR-6 2002 12 17
-
(2002)
MMWR Morb Mortal Wkly Rep
, vol.51
, Issue.RR-6
, pp. 12-17
-
-
-
3
-
-
0020567567
-
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir: A randomized double-blind controlled trial in normal subjects
-
Y.J. Bryson, M. Dillon, and M. Lovett Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir: a randomized double-blind controlled trial in normal subjects N Engl J Med 308 1983 916 921
-
(1983)
N Engl J Med
, vol.308
, pp. 916-921
-
-
Bryson, Y.J.1
Dillon, M.2
Lovett, M.3
-
4
-
-
10644248985
-
Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection
-
G.J. Mertz, C.W. Critchlow, and J. Benedetti Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection JAMA 252 1984 1147 1151
-
(1984)
JAMA
, vol.252
, pp. 1147-1151
-
-
Mertz, G.J.1
Critchlow, C.W.2
Benedetti, J.3
-
5
-
-
0031909609
-
A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections
-
The Valaciclovir International Study Group J.
-
S.K. Tyring, J.M. Douglas Jr, L. Corey, S.L. Spruance, J. Esmann The Valaciclovir International Study Group A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections Arch Dermatol 134 1998 185 191
-
(1998)
Arch Dermatol
, vol.134
, pp. 185-191
-
-
Tyring, S.K.1
Douglas Jr., J.M.2
Corey, L.3
Spruance, S.L.4
Esmann5
-
6
-
-
0021275181
-
A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection
-
J.M. Douglas, C. Critchlow, and J. Benedetti A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection N Engl J Med 310 1984 1551 1556
-
(1984)
N Engl J Med
, vol.310
, pp. 1551-1556
-
-
Douglas, J.M.1
Critchlow, C.2
Benedetti, J.3
-
7
-
-
0023920992
-
Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes
-
A. Mindel, A. Faherty, O. Carney, G. Patou, M. Freris, and P. Williams Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes Lancet 1 1988 926 928
-
(1988)
Lancet
, vol.1
, pp. 926-928
-
-
Mindel, A.1
Faherty, A.2
Carney, O.3
Patou, G.4
Freris, M.5
Williams, P.6
-
8
-
-
0023909951
-
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection: A multicenter double-blind trial
-
G.J. Mertz, C.C. Jones, and J. Mills Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection: a multicenter double-blind trial JAMA 260 1988 201 206
-
(1988)
JAMA
, vol.260
, pp. 201-206
-
-
Mertz, G.J.1
Jones, C.C.2
Mills, J.3
-
9
-
-
0021247089
-
Suppression of frequently recurring genital herpes: A placebo-controlled double-blind trial of oral acyclovir
-
S.E. Straus, H.E. Takiff, and M. Seidlin Suppression of frequently recurring genital herpes: a placebo-controlled double-blind trial of oral acyclovir N Engl J Med 310 1984 1545 1550
-
(1984)
N Engl J Med
, vol.310
, pp. 1545-1550
-
-
Straus, S.E.1
Takiff, H.E.2
Seidlin, M.3
-
10
-
-
0023767079
-
Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection
-
G.J. Mertz, L. Eron, and R. Kaufman Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection Am J Med 85 1988 14 19
-
(1988)
Am J Med
, vol.85
, pp. 14-19
-
-
Mertz, G.J.1
Eron, L.2
Kaufman, R.3
-
11
-
-
0030948337
-
Frequent genital herpes simplex virus 2 shedding in immunocompetent women: Effect of acyclovir treatment
-
A. Wald, L. Corey, R. Cone, A. Hobson, G. Davis, and J. Zeh Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment J Clin Invest 99 1997 1092 1097
-
(1997)
J Clin Invest
, vol.99
, pp. 1092-1097
-
-
Wald, A.1
Corey, L.2
Cone, R.3
Hobson, A.4
Davis, G.5
Zeh, J.6
-
12
-
-
0030025629
-
Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir
-
A. Wald, J. Zeh, G. Barnum, L.G. Davis, and L. Corey Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir Ann Intern Med 124 1996 8 15
-
(1996)
Ann Intern Med
, vol.124
, pp. 8-15
-
-
Wald, A.1
Zeh, J.2
Barnum, G.3
Davis, L.G.4
Corey, L.5
-
13
-
-
0002654202
-
Acyclovir (ACV) suspension for treatment of acute herpes simplex virus (HSV) gingivostomatitis in children: A placebo (PL) controlled, double blind trial
-
New Orleans. Abstract #1530. October 17-20
-
Aoki F.Y., Law B.J., Hammond G.W., et al. Acyclovir (ACV) suspension for treatment of acute herpes simplex virus (HSV) gingivostomatitis in children: a placebo (PL) controlled, double blind trial. Presented at 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans. Abstract #1530. October 17-20, 1993
-
(1993)
33rd Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Aoki, F.Y.1
Law, B.J.2
Hammond, G.W.3
-
14
-
-
0023811320
-
Treatment of herpes labialis with acyclovir: Review of three clinical trials
-
G.W. Raborn, W.T. McGaw, M. Grace, and J. Percy Treatment of herpes labialis with acyclovir: review of three clinical trials Am J Med 85 1988 39 42
-
(1988)
Am J Med
, vol.85
, pp. 39-42
-
-
Raborn, G.W.1
McGaw, W.T.2
Grace, M.3
Percy, J.4
-
15
-
-
0023371198
-
Oral acyclovir and herpes labialis: A randomized, double-blind, placebo-controlled study
-
G.W. Raborn, W.T. McGaw, M. Grace, L.D. Tyrrell, and S.M. Samuels Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study J Am Dent Assoc 115 1987 38 42
-
(1987)
J Am Dent Assoc
, vol.115
, pp. 38-42
-
-
Raborn, G.W.1
McGaw, W.T.2
Grace, M.3
Tyrrell, L.D.4
Samuels, S.M.5
-
16
-
-
0025159265
-
Treatment of recurrent herpes simplex labialis with oral acyclovir
-
S.L. Spruance, J.C. Stewart, N.H. Rowe, M.B. McKeough, G. Wenerstrom, and D.J. Freeman Treatment of recurrent herpes simplex labialis with oral acyclovir J Infect Dis 161 1990 185 190
-
(1990)
J Infect Dis
, vol.161
, pp. 185-190
-
-
Spruance, S.L.1
Stewart, J.C.2
Rowe, N.H.3
McKeough, M.B.4
Wenerstrom, G.5
Freeman, D.J.6
-
17
-
-
0023802762
-
Acyclovir prevents reactivation of herpes simplex labialis in skiers
-
S.L. Spruance, M.L. Hamill, W.S. Hoge, L.G. Davis, and J. Mills Acyclovir prevents reactivation of herpes simplex labialis in skiers JAMA 260 1988 1597 1599
-
(1988)
JAMA
, vol.260
, pp. 1597-1599
-
-
Spruance, S.L.1
Hamill, M.L.2
Hoge, W.S.3
Davis, L.G.4
Mills, J.5
-
18
-
-
0023154559
-
Acyclovir prophylaxis for herpes simplex virus infection
-
D. Gold, and L. Corey Acyclovir prophylaxis for herpes simplex virus infection Antimicrob Agents Chemother 31 1987 361 367
-
(1987)
Antimicrob Agents Chemother
, vol.31
, pp. 361-367
-
-
Gold, D.1
Corey, L.2
-
19
-
-
0025852259
-
The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir
-
S.L. Spruance, D.J. Freeman, and J.C. Stewart The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir J Infect Dis 163 1991 728 734
-
(1991)
J Infect Dis
, vol.163
, pp. 728-734
-
-
Spruance, S.L.1
Freeman, D.J.2
Stewart, J.C.3
-
20
-
-
0027410563
-
Oral acyclovir to suppress frequently recurrent herpes labialis: A double-blind, placebo-controlled trial
-
J.F. Rooney, S.E. Straus, and M.L. Mannix Oral acyclovir to suppress frequently recurrent herpes labialis: a double-blind, placebo-controlled trial Ann Intern Med 118 1993 268 272
-
(1993)
Ann Intern Med
, vol.118
, pp. 268-272
-
-
Rooney, J.F.1
Straus, S.E.2
Mannix, M.L.3
-
21
-
-
0022645112
-
Vidarabine versus acyclovir therapy in herpes simplex encephalitis
-
R.J. Whitley, C.A. Alford, and M.S. Hirsch Vidarabine versus acyclovir therapy in herpes simplex encephalitis N Engl J Med 314 1986 144 149
-
(1986)
N Engl J Med
, vol.314
, pp. 144-149
-
-
Whitley, R.J.1
Alford, C.A.2
Hirsch, M.S.3
-
22
-
-
0021145262
-
Acyclovir versus vidarabine in herpes simplex encephalitis: Randomised multicentre study in consecutive Swedish patients
-
B. Skoldenberg, M. Forsgren, and K. Alestig Acyclovir versus vidarabine in herpes simplex encephalitis: randomised multicentre study in consecutive Swedish patients Lancet 2 1984 707 711
-
(1984)
Lancet
, vol.2
, pp. 707-711
-
-
Skoldenberg, B.1
Forsgren, M.2
Alestig, K.3
-
23
-
-
17844406875
-
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections
-
D.W. Kimberlin, C.Y. Lin, and R.F. Jacobs Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections Pediatrics 108 2001 230 238
-
(2001)
Pediatrics
, vol.108
, pp. 230-238
-
-
Kimberlin, D.W.1
Lin, C.Y.2
Jacobs, R.F.3
-
24
-
-
0344545247
-
Herpes simplex
-
American Academy of Pediatrics L.K. Pickering 26th edition American Academy of Pediatrics Elk Grove Village (IL)
-
American Academy of Pediatrics Herpes simplex L.K. Pickering Red Book: 2003 report of the Committee on Infectious Diseases 26th edition 2003 American Academy of Pediatrics Elk Grove Village (IL) 344 353
-
(2003)
Red Book: 2003 Report of the Committee on Infectious Diseases
, pp. 344-353
-
-
-
25
-
-
0018948443
-
Vidarabine therapy of neonatal herpes simplex virus infection
-
R.J. Whitley, A.J. Nahmias, S.J. Soong, G.G. Galasso, C.L. Fleming, and C.A. Alford Vidarabine therapy of neonatal herpes simplex virus infection Pediatrics 66 1980 495 501
-
(1980)
Pediatrics
, vol.66
, pp. 495-501
-
-
Whitley, R.J.1
Nahmias, A.J.2
Soong, S.J.3
Galasso, G.G.4
Fleming, C.L.5
Alford, C.A.6
-
26
-
-
0020042788
-
Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: A double-blind trial
-
J.C. Wade, B. Newton, C. McLaren, N. Flournoy, R.E. Keeney, and J.D. Meyers Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial Ann Intern Med 96 1982 265 269
-
(1982)
Ann Intern Med
, vol.96
, pp. 265-269
-
-
Wade, J.C.1
Newton, B.2
McLaren, C.3
Flournoy, N.4
Keeney, R.E.5
Meyers, J.D.6
-
27
-
-
0042690233
-
Antiviral agents
-
S.S. Long L.K. Pickering C.G. Prober 2nd edition Churchill Livingstone Philadelphia
-
D.W. Kimberlin, and C.G. Prober Antiviral agents S.S. Long L.K. Pickering C.G. Prober Principles and practice of pediatric infectious diseases 2nd edition 2003 Churchill Livingstone Philadelphia 1527 1547
-
(2003)
Principles and Practice of Pediatric Infectious Diseases
, pp. 1527-1547
-
-
Kimberlin, D.W.1
Prober, C.G.2
-
28
-
-
0019933062
-
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host
-
J.D. Meyers, J.C. Wade, and C.D. Mitchell Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host Am J Med 73 1982 229 235
-
(1982)
Am J Med
, vol.73
, pp. 229-235
-
-
Meyers, J.D.1
Wade, J.C.2
Mitchell, C.D.3
-
29
-
-
0021867519
-
Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients
-
D.H. Shepp, B.A. Newton, P.S. Dandliker, N. Flournoy, and J.D. Meyers Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients Ann Intern Med 102 1985 783 785
-
(1985)
Ann Intern Med
, vol.102
, pp. 783-785
-
-
Shepp, D.H.1
Newton, B.A.2
Dandliker, P.S.3
Flournoy, N.4
Meyers, J.D.5
-
30
-
-
0024601339
-
A comparison between acyclovir and trifluorothymidine ophthalmic ointment in the treatment of epithelial dendritic keratitis: A double blind, randomized parallel group trial
-
G. Hovding A comparison between acyclovir and trifluorothymidine ophthalmic ointment in the treatment of epithelial dendritic keratitis: a double blind, randomized parallel group trial Acta Ophthalmol (Copenh) 67 1989 51 54
-
(1989)
Acta Ophthalmol (Copenh)
, vol.67
, pp. 51-54
-
-
Hovding, G.1
-
31
-
-
7344245411
-
Acyclovir for the prevention of recurrent herpes simplex virus eye disease
-
Herpetic Eye Disease Study Group
-
Herpetic Eye Disease Study Group Acyclovir for the prevention of recurrent herpes simplex virus eye disease N Engl J Med 339 1998 300 306
-
(1998)
N Engl J Med
, vol.339
, pp. 300-306
-
-
-
32
-
-
0033869897
-
Oral acyclovir for herpes simplex virus eye disease: Effect on prevention of epithelial keratitis and stromal keratitis
-
Herpetic Eye Disease Study Group
-
Herpetic Eye Disease Study Group Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis Arch Ophthalmol 118 2000 1030 1036
-
(2000)
Arch Ophthalmol
, vol.118
, pp. 1030-1036
-
-
-
33
-
-
0026718750
-
Therapeutic approaches to varicella-zoster virus infections
-
R.J. Whitley Therapeutic approaches to varicella-zoster virus infections J Infect Dis 166 1992 S51 S57
-
(1992)
J Infect Dis
, vol.166
-
-
Whitley, R.J.1
-
34
-
-
0026410702
-
A controlled trial of acyclovir for chickenpox in normal children
-
L.M. Dunkle, A.M. Arvin, and R.J. Whitley A controlled trial of acyclovir for chickenpox in normal children N Engl J Med 325 1991 1539 1544
-
(1991)
N Engl J Med
, vol.325
, pp. 1539-1544
-
-
Dunkle, L.M.1
Arvin, A.M.2
Whitley, R.J.3
-
35
-
-
0026511362
-
Acyclovir treatment of varicella in otherwise healthy adolescents
-
H.H. Balfour Jr, H.A. Rotbart, and S. Feldman Acyclovir treatment of varicella in otherwise healthy adolescents J Pediatr 120 1992 627 633
-
(1992)
J Pediatr
, vol.120
, pp. 627-633
-
-
Balfour Jr., H.H.1
Rotbart, H.A.2
Feldman, S.3
-
36
-
-
0026738571
-
Treatment of adult varicella with oral acyclovir: A randomized, placebo-controlled trial
-
M.R. Wallace, W.A. Bowler, N.B. Murray, S.K. Brodine, and E.C. Oldfield 3rd Treatment of adult varicella with oral acyclovir: a randomized, placebo-controlled trial Ann Intern Med 117 1992 358 363
-
(1992)
Ann Intern Med
, vol.117
, pp. 358-363
-
-
Wallace, M.R.1
Bowler, W.A.2
Murray, N.B.3
Brodine, S.K.4
Oldfield III, E.C.5
-
37
-
-
0002414247
-
Therapy for varicella-zoster virus infections: Where do we stand?
-
R.J. Whitley, and S.E. Straus Therapy for varicella-zoster virus infections: where do we stand? Infect Dis Clin Pract 2 1993 100 108
-
(1993)
Infect Dis Clin Pract
, vol.2
, pp. 100-108
-
-
Whitley, R.J.1
Straus, S.E.2
-
38
-
-
0020644915
-
Intravenous acyclovir in acute herpes zoster infection
-
J. McGill, D.R. MacDonald, C. Fall, G.D. McKendrick, and A. Copplestone Intravenous acyclovir in acute herpes zoster infection J Infect 6 1983 157 161
-
(1983)
J Infect
, vol.6
, pp. 157-161
-
-
McGill, J.1
MacDonald, D.R.2
Fall, C.3
McKendrick, G.D.4
Copplestone, A.5
-
39
-
-
0023687047
-
Efficacy of oral acyclovir treatment of acute herpes zoster
-
M.J. Wood, P.H. Ogan, M.W. McKendrick, C.D. Care, J.I. McGill, and E.M. Webb Efficacy of oral acyclovir treatment of acute herpes zoster Am J Med 85 1988 79 83
-
(1988)
Am J Med
, vol.85
, pp. 79-83
-
-
Wood, M.J.1
Ogan, P.H.2
McKendrick, M.W.3
Care, C.D.4
McGill, J.I.5
Webb, E.M.6
-
40
-
-
0025237876
-
Herpes simplex virus resistant to acyclovir: A study in a tertiary care center
-
J.A. Englund, M.E. Zimmerman, E.M. Swierkosz, J.L. Goodman, D.R. Scholl, and H.H. Balfour Jr Herpes simplex virus resistant to acyclovir: a study in a tertiary care center Ann Intern Med 112 1990 416 422
-
(1990)
Ann Intern Med
, vol.112
, pp. 416-422
-
-
Englund, J.A.1
Zimmerman, M.E.2
Swierkosz, E.M.3
Goodman, J.L.4
Scholl, D.R.5
Balfour Jr., H.H.6
-
41
-
-
0025371895
-
Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS
-
A. Gateley, R.M. Gander, P.C. Johnson, S. Kit, H. Otsuka, and S. Kohl Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS J Infect Dis 161 1990 711 715
-
(1990)
J Infect Dis
, vol.161
, pp. 711-715
-
-
Gateley, A.1
Gander, R.M.2
Johnson, P.C.3
Kit, S.4
Otsuka, H.5
Kohl, S.6
-
42
-
-
0027362888
-
Brief report: Recurrent acyclovir-resistant genital herpes in an immunocompetent patient
-
R.G. Kost, E.L. Hill, M. Tigges, and S.E. Straus Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient N Engl J Med 329 1993 1777 1782
-
(1993)
N Engl J Med
, vol.329
, pp. 1777-1782
-
-
Kost, R.G.1
Hill, E.L.2
Tigges, M.3
Straus, S.E.4
-
44
-
-
0028006272
-
Aciclovir: A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy
-
A.J. Wagstaff, D. Faulds, and K.L. Goa Aciclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy Drugs 47 1994 153 205
-
(1994)
Drugs
, vol.47
, pp. 153-205
-
-
Wagstaff, A.J.1
Faulds, D.2
Goa, K.L.3
-
45
-
-
9044244911
-
Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial
-
D. Kimberlin, D. Powell, and W. Gruber Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial Pediatr Infect Dis J 15 1996 247 254
-
(1996)
Pediatr Infect Dis J
, vol.15
, pp. 247-254
-
-
Kimberlin, D.1
Powell, D.2
Gruber, W.3
-
46
-
-
17844396896
-
Natural history of neonatal herpes simplex virus infections in the acyclovir era
-
D.W. Kimberlin, C.Y. Lin, and R.F. Jacobs Natural history of neonatal herpes simplex virus infections in the acyclovir era Pediatrics 108 2001 223 229
-
(2001)
Pediatrics
, vol.108
, pp. 223-229
-
-
Kimberlin, D.W.1
Lin, C.Y.2
Jacobs, R.F.3
-
47
-
-
0029128533
-
Delirium associated with acyclovir treatment in a patient with renal failure
-
S.G. Revankar, A.L. Applegate, and D.M. Markovitz Delirium associated with acyclovir treatment in a patient with renal failure Clin Infect Dis 21 1995 435 436
-
(1995)
Clin Infect Dis
, vol.21
, pp. 435-436
-
-
Revankar, S.G.1
Applegate, A.L.2
Markovitz, D.M.3
-
48
-
-
2342559854
-
Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the International Acyclovir Pregnancy Registry, 1984-1999
-
K.M. Stone, R. Reiff-Eldridge, and A.D. White Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the International Acyclovir Pregnancy Registry, 1984-1999 Birth Defects Res 70 2004 201 207
-
(2004)
Birth Defects Res
, vol.70
, pp. 201-207
-
-
Stone, K.M.1
Reiff-Eldridge, R.2
White, A.D.3
-
49
-
-
0027752108
-
Valaciclovir (BW256U87): The L-valyl ester of acyclovir
-
M.A. Jacobson Valaciclovir (BW256U87): the L-valyl ester of acyclovir J Med Virol Suppl 1 1993 150 153
-
(1993)
J Med Virol
, Issue.SUPPL. 1
, pp. 150-153
-
-
Jacobson, M.A.1
-
50
-
-
9844223399
-
Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection: Results of an international, multicenter, double-blind, randomized clinical trial
-
The Valaciclovir International Herpes Simplex Virus Study Group R.
-
K.H. Fife, R.A. Barbarash, T. Rudolph, B. Degregorio, R. Roth The Valaciclovir International Herpes Simplex Virus Study Group Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection: results of an international, multicenter, double-blind, randomized clinical trial Sex Transm Dis 24 1997 481 486
-
(1997)
Sex Transm Dis
, vol.24
, pp. 481-486
-
-
Fife, K.H.1
Barbarash, R.A.2
Rudolph, T.3
Degregorio, B.4
Roth5
-
51
-
-
0029798884
-
A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis
-
The Valaciclovir HSV Study Group K.
-
S.L. Spruance, S.K. Tyring, B. DeGregorio, C. Miller, K. Beutner The Valaciclovir HSV Study Group A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis Arch Intern Med 156 1996 1729 1735
-
(1996)
Arch Intern Med
, vol.156
, pp. 1729-1735
-
-
Spruance, S.L.1
Tyring, S.K.2
Degregorio, B.3
Miller, C.4
Beutner5
-
52
-
-
0036531893
-
Valacyclovir for episodic treatment of genital herpes: A shorter 3-day treatment course compared with 5-day treatment
-
P.A. Leone, S. Trottier, and J.M. Miller Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment Clin Infect Dis 34 2002 958 962
-
(2002)
Clin Infect Dis
, vol.34
, pp. 958-962
-
-
Leone, P.A.1
Trottier, S.2
Miller, J.M.3
-
53
-
-
0031688110
-
Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: A large-scale dose range-finding study
-
M. Reitano, S. Tyring, and W. Lang Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study J Infect Dis 178 1998 603 610
-
(1998)
J Infect Dis
, vol.178
, pp. 603-610
-
-
Reitano, M.1
Tyring, S.2
Lang, W.3
-
54
-
-
0037416977
-
High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: Results of two randomized, placebo-controlled, multicenter studies
-
S.L. Spruance, T.M. Jones, and M.M. Blatter High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies Antimicrob Agents Chemother 47 2003 1072 1080
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 1072-1080
-
-
Spruance, S.L.1
Jones, T.M.2
Blatter, M.M.3
-
55
-
-
0037607554
-
Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies
-
D. Baker, and D. Eisen Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies Cutis 71 2003 239 242
-
(2003)
Cutis
, vol.71
, pp. 239-242
-
-
Baker, D.1
Eisen, D.2
-
56
-
-
0012729633
-
Valacyclovir effective for suppression of recurrent HSV-1 herpes labialis
-
Toronto, Ontario, Canada. Abstract #464. September 17-20
-
Baker D.A., Deeter R.G., Redder K., Phillips J.A. Valacyclovir effective for suppression of recurrent HSV-1 herpes labialis. Presented at 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, Canada. Abstract #464. September 17-20, 2000
-
(2000)
40th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Baker, D.A.1
Deeter, R.G.2
Redder, K.3
Phillips, J.A.4
-
57
-
-
0029062086
-
Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults
-
K.R. Beutner, D.J. Friedman, C. Forszpaniak, P.L. Andersen, and M.J. Wood Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults Antimicrob Agents Chemother 39 1995 1546 1553
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 1546-1553
-
-
Beutner, K.R.1
Friedman, D.J.2
Forszpaniak, C.3
Andersen, P.L.4
Wood, M.J.5
-
58
-
-
0028883462
-
Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans
-
J. Soul-Lawton, E. Seaber, N. On, R. Wootton, P. Rolan, and J. Posner Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans Antimicrob Agents Chemother 39 1995 2759 2764
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 2759-2764
-
-
Soul-Lawton, J.1
Seaber, E.2
On, N.3
Wootton, R.4
Rolan, P.5
Posner, J.6
-
59
-
-
0030773132
-
Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204)
-
W.R. Bell, J.D. Chulay, and J.E. Feinberg Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204) Medicine 76 1997 369 380
-
(1997)
Medicine
, vol.76
, pp. 369-380
-
-
Bell, W.R.1
Chulay, J.D.2
Feinberg, J.E.3
-
60
-
-
0026342128
-
Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus
-
G. Andrei, R. Snoeck, D. Schols, P. Goubau, J. Desmyter, and E. De Clercq Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus Eur J Clin Microbiol Infect Dis 10 1991 1026 1033
-
(1991)
Eur J Clin Microbiol Infect Dis
, vol.10
, pp. 1026-1033
-
-
Andrei, G.1
Snoeck, R.2
Schols, D.3
Goubau, P.4
Desmyter, J.5
De Clercq, E.6
-
61
-
-
0033281850
-
Cidofovir: Review of current and potential clinical uses
-
S. Safrin, J. Cherrington, and H.S. Jaffe Cidofovir: review of current and potential clinical uses Adv Exp Med Biol 458 1999 111 120
-
(1999)
Adv Exp Med Biol
, vol.458
, pp. 111-120
-
-
Safrin, S.1
Cherrington, J.2
Jaffe, H.S.3
-
62
-
-
0028064563
-
Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]- cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS
-
J.P. Lalezari, W.L. Drew, and E. Glutzer Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS J Infect Dis 170 1994 570 572
-
(1994)
J Infect Dis
, vol.170
, pp. 570-572
-
-
Lalezari, J.P.1
Drew, W.L.2
Glutzer, E.3
-
63
-
-
1842294582
-
Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC peripheral cytomegalovirus retinitis trial: A randomized, controlled trial
-
Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group
-
Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial: a randomized, controlled trial Ann Intern Med 126 1997 264 274
-
(1997)
Ann Intern Med
, vol.126
, pp. 264-274
-
-
-
64
-
-
0031051578
-
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: A randomized, controlled trial
-
J.P. Lalezari, R.J. Stagg, and B.D. Kuppermann Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial Ann Intern Med 126 1997 257 263
-
(1997)
Ann Intern Med
, vol.126
, pp. 257-263
-
-
Lalezari, J.P.1
Stagg, R.J.2
Kuppermann, B.D.3
-
65
-
-
0028271126
-
Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir
-
N.S. Lurain, L.E. Spafford, and K.D. Thompson Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir J Virol 68 1994 4427 4431
-
(1994)
J Virol
, vol.68
, pp. 4427-4431
-
-
Lurain, N.S.1
Spafford, L.E.2
Thompson, K.D.3
-
66
-
-
0026476302
-
Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents
-
N.S. Lurain, K.D. Thompson, E.W. Holmes, and G.S. Read Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents J Virol 66 1992 7146 7152
-
(1992)
J Virol
, vol.66
, pp. 7146-7152
-
-
Lurain, N.S.1
Thompson, K.D.2
Holmes, E.W.3
Read, G.S.4
-
68
-
-
0026537658
-
Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2- (phosphonylmethoxy)propyl]cytosine
-
H.T. Ho, K.L. Woods, J.J. Bronson, H. De Boeck, J.C. Martin, and M.J. Hitchcock Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2- (phosphonylmethoxy)propyl]cytosine Mol Pharmacol 41 1992 197 202
-
(1992)
Mol Pharmacol
, vol.41
, pp. 197-202
-
-
Ho, H.T.1
Woods, K.L.2
Bronson, J.J.3
De Boeck, H.4
Martin, J.C.5
Hitchcock, M.J.6
-
69
-
-
0029000871
-
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients
-
K.C. Cundy, B.G. Petty, and J. Flaherty Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients Antimicrob Agents Chemother 39 1995 1247 1252
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 1247-1252
-
-
Cundy, K.C.1
Petty, B.G.2
Flaherty, J.3
-
70
-
-
0028936048
-
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): Results of a phase I/II study of a novel antiviral nucleotide analogue
-
J.P. Lalezari, W.L. Drew, and E. Glutzer (S)-1-[3-hydroxy-2- (phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue J Infect Dis 171 1995 788 796
-
(1995)
J Infect Dis
, vol.171
, pp. 788-796
-
-
Lalezari, J.P.1
Drew, W.L.2
Glutzer, E.3
-
71
-
-
0029957145
-
Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: A randomized, double-blind multicenter trial
-
The Canadian Famciclovir Study Group S.D.
-
S.L. Sacks, F.Y. Aoki, F. Diaz-Mitoma, J. Sellors, S.D. Shafran The Canadian Famciclovir Study Group Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: a randomized, double-blind multicenter trial JAMA 276 1996 44 49
-
(1996)
JAMA
, vol.276
, pp. 44-49
-
-
Sacks, S.L.1
Aoki, F.Y.2
Diaz-Mitoma, F.3
Sellors, J.4
Shafran5
-
72
-
-
0032500278
-
Oral famciclovir for the suppression of recurrent genital herpes: A randomized controlled trial
-
The Collaborative Famciclovir Genital Herpes Research Group R.L.
-
F. Diaz-Mitoma, R.G. Sibbald, S.D. Shafran, R. Boon, R.L. Saltzman The Collaborative Famciclovir Genital Herpes Research Group Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial JAMA 280 1998 887 892
-
(1998)
JAMA
, vol.280
, pp. 887-892
-
-
Diaz-Mitoma, F.1
Sibbald, R.G.2
Shafran, S.D.3
Boon, R.4
Saltzman5
-
73
-
-
0031030411
-
Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women: A multicenter, double-blind, placebo-controlled trial
-
G.J. Mertz, M.O. Loveless, and M.J. Levin Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women: a multicenter, double-blind, placebo-controlled trial Arch Intern Med 157 1997 343 349
-
(1997)
Arch Intern Med
, vol.157
, pp. 343-349
-
-
Mertz, G.J.1
Loveless, M.O.2
Levin, M.J.3
-
74
-
-
0033975527
-
Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: A randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group
-
R. Boon, J.J. Goodman, J. Martinez, G.L. Marks, M. Gamble, and C. Welch Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group Clin Ther 22 2000 76 90
-
(2000)
Clin Ther
, vol.22
, pp. 76-90
-
-
Boon, R.1
Goodman, J.J.2
Martinez, J.3
Marks, G.L.4
Gamble, M.5
Welch, C.6
-
75
-
-
0030898625
-
Penciclovir cream for the treatment of herpes simplex labialis: A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group
-
S.L. Spruance, T.L. Rea, C. Thoming, R. Tucker, R. Saltzman, and R. Boon Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group JAMA 277 1997 1374 1379
-
(1997)
JAMA
, vol.277
, pp. 1374-1379
-
-
Spruance, S.L.1
Rea, T.L.2
Thoming, C.3
Tucker, R.4
Saltzman, R.5
Boon, R.6
-
76
-
-
0029113580
-
Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia: A randomized, double-blind, placebo-controlled trial
-
S. Tyring, R.A. Barbarash, and J.E. Nahlik Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial Ann Intern Med 123 1995 89 96
-
(1995)
Ann Intern Med
, vol.123
, pp. 89-96
-
-
Tyring, S.1
Barbarash, R.A.2
Nahlik, J.E.3
-
77
-
-
0028271152
-
Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment
-
S.C. Boike, M.A. Pue, and M.I. Freed Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment Clin Pharmacol Ther 55 1994 418 426
-
(1994)
Clin Pharmacol Ther
, vol.55
, pp. 418-426
-
-
Boike, S.C.1
Pue, M.A.2
Freed, M.I.3
-
78
-
-
0026518319
-
Cytomegalovirus infection in patients with AIDS
-
W.L. Drew Cytomegalovirus infection in patients with AIDS Clin Infect Dis 14 1992 608 615
-
(1992)
Clin Infect Dis
, vol.14
, pp. 608-615
-
-
Drew, W.L.1
-
79
-
-
0027408358
-
Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients
-
D.T. Dieterich, M.A. Poles, and E.A. Lew Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients J Infect Dis 167 1993 1184 1188
-
(1993)
J Infect Dis
, vol.167
, pp. 1184-1188
-
-
Dieterich, D.T.1
Poles, M.A.2
Lew, E.A.3
-
80
-
-
0034085104
-
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients
-
B.M. Anduze-Faris, A.M. Fillet, and J. Gozlan Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients AIDS 14 2000 517 524
-
(2000)
AIDS
, vol.14
, pp. 517-524
-
-
Anduze-Faris, B.M.1
Fillet, A.M.2
Gozlan, J.3
-
81
-
-
0027506750
-
Ganciclovir treatment of cytomegalovirus colitis in AIDS: A randomized, double-blind, placebo-controlled multicenter study
-
D.T. Dieterich, D.P. Kotler, and D.F. Busch Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study J Infect Dis 167 1993 278 282
-
(1993)
J Infect Dis
, vol.167
, pp. 278-282
-
-
Dieterich, D.T.1
Kotler, D.P.2
Busch, D.F.3
-
82
-
-
0025361146
-
Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients: A randomized, placebo-controlled trial
-
E.C. Reed, J.L. Wolford, and K.J. Kopecky Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients: a randomized, placebo-controlled trial Ann Intern Med 112 1990 505 510
-
(1990)
Ann Intern Med
, vol.112
, pp. 505-510
-
-
Reed, E.C.1
Wolford, J.L.2
Kopecky, K.J.3
-
83
-
-
0024232608
-
Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants
-
E.C. Reed, R.A. Bowden, P.S. Dandliker, K.E. Lilleby, and J.D. Meyers Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants Ann Intern Med 109 1988 783 788
-
(1988)
Ann Intern Med
, vol.109
, pp. 783-788
-
-
Reed, E.C.1
Bowden, R.A.2
Dandliker, P.S.3
Lilleby, K.E.4
Meyers, J.D.5
-
84
-
-
0024230867
-
Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin
-
D. Emanuel, I. Cunningham, and K. Jules-Elysee Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin Ann Intern Med 109 1988 777 782
-
(1988)
Ann Intern Med
, vol.109
, pp. 777-782
-
-
Emanuel, D.1
Cunningham, I.2
Jules-Elysee, K.3
-
85
-
-
0033292036
-
Preemptive therapy in CMV-antigen positive patients after liver transplantation-a prospective trial
-
N. Rayes, H. Oettle, and C.A. Schmidt Preemptive therapy in CMV-antigen positive patients after liver transplantation-a prospective trial Ann Transplant 4 1999 12 17
-
(1999)
Ann Transplant
, vol.4
, pp. 12-17
-
-
Rayes, N.1
Oettle, H.2
Schmidt, C.A.3
-
86
-
-
0034035775
-
Comparison of the efficacy and cost effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients
-
J. Kelly, D. Hurley, and G. Raghu Comparison of the efficacy and cost effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients J Heart Lung Transplant 19 2000 355 359
-
(2000)
J Heart Lung Transplant
, vol.19
, pp. 355-359
-
-
Kelly, J.1
Hurley, D.2
Raghu, G.3
-
87
-
-
0034070233
-
Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation
-
T. Mori, S. Okamoto, and S. Matsuoka Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation Bone Marrow Transplant 25 2000 765 769
-
(2000)
Bone Marrow Transplant
, vol.25
, pp. 765-769
-
-
Mori, T.1
Okamoto, S.2
Matsuoka, S.3
-
88
-
-
0032785374
-
Management of allogeneic bone marrow transplant recipients at risk for cytomegalovirus disease using a surveillance bronchoscopy and prolonged pre-emptive ganciclovir therapy
-
V. Reddy, Y. Hao, and J. Lipton Management of allogeneic bone marrow transplant recipients at risk for cytomegalovirus disease using a surveillance bronchoscopy and prolonged pre-emptive ganciclovir therapy J Clin Virol 13 1999 149 159
-
(1999)
J Clin Virol
, vol.13
, pp. 149-159
-
-
Reddy, V.1
Hao, Y.2
Lipton, J.3
-
89
-
-
0032521302
-
Preemptive treatment for the prevention of cytomegalovirus disease: In lung and heart transplant recipients
-
J.J. Egan, J. Lomax, and L. Barber Preemptive treatment for the prevention of cytomegalovirus disease: in lung and heart transplant recipients Transplantation 65 1998 747 752
-
(1998)
Transplantation
, vol.65
, pp. 747-752
-
-
Egan, J.J.1
Lomax, J.2
Barber, L.3
-
90
-
-
0026492721
-
Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients
-
S.R. Duncan, I.L. Paradis, J.H. Dauber, S.A. Yousem, R.L. Hardesty, and B.P. Griffith Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients Am Rev Respir Dis 146 1992 1213 1215
-
(1992)
Am Rev Respir Dis
, vol.146
, pp. 1213-1215
-
-
Duncan, S.R.1
Paradis, I.L.2
Dauber, J.H.3
Yousem, S.A.4
Hardesty, R.L.5
Griffith, B.P.6
-
91
-
-
0026594210
-
A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation
-
T.C. Merigan, D.G. Renlund, and S. Keay A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation N Engl J Med 326 1992 1182 1186
-
(1992)
N Engl J Med
, vol.326
, pp. 1182-1186
-
-
Merigan, T.C.1
Renlund, D.G.2
Keay, S.3
-
92
-
-
0031441891
-
Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors
-
P. Seu, D.J. Winston, C.D. Holt, F. Kaldas, and R.W. Busuttil Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors Transplantation 64 1997 1614 1617
-
(1997)
Transplantation
, vol.64
, pp. 1614-1617
-
-
Seu, P.1
Winston, D.J.2
Holt, C.D.3
Kaldas, F.4
Busuttil, R.W.5
-
93
-
-
0042243568
-
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial
-
D.W. Kimberlin, C.Y. Lin, and P.J. Sanchez Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial J Pediatr 143 2003 16 25
-
(2003)
J Pediatr
, vol.143
, pp. 16-25
-
-
Kimberlin, D.W.1
Lin, C.Y.2
Sanchez, P.J.3
-
94
-
-
0028059453
-
Ganciclovir: An update of its therapeutic use in cytomegalovirus infection
-
A. Markham, and D. Faulds Ganciclovir: an update of its therapeutic use in cytomegalovirus infection Drugs 48 1994 455 484
-
(1994)
Drugs
, vol.48
, pp. 455-484
-
-
Markham, A.1
Faulds, D.2
-
95
-
-
0033681577
-
Oral ganciclovir in children: Pharmacokinetics, safety, tolerance, and antiviral effects
-
L.M. Frenkel, E.V. Capparelli, and W.M. Dankner Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects J Infect Dis 182 2000 1616 1624
-
(2000)
J Infect Dis
, vol.182
, pp. 1616-1624
-
-
Frenkel, L.M.1
Capparelli, E.V.2
Dankner, W.M.3
-
97
-
-
0022551586
-
Human pharmacokinetics of the antiviral drug DHPG
-
C. Fletcher, R. Sawchuk, B. Chinnock, P. de Miranda, and H.H. Balfour Jr Human pharmacokinetics of the antiviral drug DHPG Clin Pharmacol Ther 40 1986 281 286
-
(1986)
Clin Pharmacol Ther
, vol.40
, pp. 281-286
-
-
Fletcher, C.1
Sawchuk, R.2
Chinnock, B.3
De Miranda, P.4
Balfour Jr., H.H.5
-
98
-
-
0026073927
-
Pharmacokinetics of ganciclovir in a patient undergoing hemodialysis
-
S.K. Swan, M.Y. Munar, M.A. Wigger, and W.M. Bennett Pharmacokinetics of ganciclovir in a patient undergoing hemodialysis Am J Kidney Dis 17 1991 69 72
-
(1991)
Am J Kidney Dis
, vol.17
, pp. 69-72
-
-
Swan, S.K.1
Munar, M.Y.2
Wigger, M.A.3
Bennett, W.M.4
-
99
-
-
0028863049
-
Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens
-
S.A. Spector, K. Hsia, D. Wolf, M. Shinkai, and I. Smith Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens Clin Infect Dis 21 1995 S170 S173
-
(1995)
Clin Infect Dis
, vol.21
-
-
Spector, S.A.1
Hsia, K.2
Wolf, D.3
Shinkai, M.4
Smith, I.5
-
100
-
-
0036014080
-
Valganciclovir: An advance in cytomegalovirus therapeutics
-
J.M. Cocohoba, and I.R. McNicholl Valganciclovir: an advance in cytomegalovirus therapeutics Ann Pharmacother 36 2002 1075 1079
-
(2002)
Ann Pharmacother
, vol.36
, pp. 1075-1079
-
-
Cocohoba, J.M.1
McNicholl, I.R.2
-
101
-
-
0037061903
-
A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis
-
D.F. Martin, J. Sierra-Madero, and S. Walmsley A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis N Engl J Med 346 2002 1119 1126
-
(2002)
N Engl J Med
, vol.346
, pp. 1119-1126
-
-
Martin, D.F.1
Sierra-Madero, J.2
Walmsley, S.3
-
102
-
-
0033325221
-
Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects
-
D. Jung, and A. Dorr Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects J Clin Pharmacol 39 1999 800 804
-
(1999)
J Clin Pharmacol
, vol.39
, pp. 800-804
-
-
Jung, D.1
Dorr, A.2
-
103
-
-
0032873150
-
Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers
-
F. Brown, L. Banken, K. Saywell, and I. Arum Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers Clin Pharmacokinet 37 1999 167 176
-
(1999)
Clin Pharmacokinet
, vol.37
, pp. 167-176
-
-
Brown, F.1
Banken, L.2
Saywell, K.3
Arum, I.4
-
104
-
-
0020326471
-
Trifluridine: A review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections
-
A.A. Carmine, R.N. Brogden, R.C. Heel, T.M. Speight, and G.S. Avery Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections Drugs 23 1982 329 353
-
(1982)
Drugs
, vol.23
, pp. 329-353
-
-
Carmine, A.A.1
Brogden, R.N.2
Heel, R.C.3
Speight, T.M.4
Avery, G.S.5
-
105
-
-
0002203144
-
Major ocular viral infections
-
G.J. Galasso R.J. Whitley T.C. Merigan 3rd edition Raven Press New York
-
D. Pavan-Langston Major ocular viral infections G.J. Galasso R.J. Whitley T.C. Merigan Antiviral agents and viral diseases of man 3rd edition 1990 Raven Press New York 183 233
-
(1990)
Antiviral Agents and Viral Diseases of Man
, pp. 183-233
-
-
Pavan-Langston, D.1
-
106
-
-
0016794684
-
Adenine arabinoside in idoxuridine unresponsive and intolerant herpetic keratitis
-
R.A. Hyndiuk, D.S. Hull, R.O. Schultz, and G.N. Chin Adenine arabinoside in idoxuridine unresponsive and intolerant herpetic keratitis Am J Ophthalmol 79 1975 655 658
-
(1975)
Am J Ophthalmol
, vol.79
, pp. 655-658
-
-
Hyndiuk, R.A.1
Hull, D.S.2
Schultz, R.O.3
Chin, G.N.4
-
107
-
-
0015371641
-
A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis
-
D. Pavan-Langston, and C.H. Dohlman A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis Am J Ophthalmol 74 1972 81 88
-
(1972)
Am J Ophthalmol
, vol.74
, pp. 81-88
-
-
Pavan-Langston, D.1
Dohlman, C.H.2
-
108
-
-
0017123094
-
Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus
-
D.J. Coster, J.R. McKinnon, J.I. McGill, B.R. Jones, and F.T. Fraunfelder Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus J Infect Dis 133 1976 A173
-
(1976)
J Infect Dis
, vol.133
, pp. 173
-
-
Coster, D.J.1
McKinnon, J.R.2
McGill, J.I.3
Jones, B.R.4
Fraunfelder, F.T.5
-
109
-
-
0026006264
-
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS
-
M.A. Jacobson, W.L. Drew, and J. Feinberg Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS J Infect Dis 163 1991 1348 1351
-
(1991)
J Infect Dis
, vol.163
, pp. 1348-1351
-
-
Jacobson, M.A.1
Drew, W.L.2
Feinberg, J.3
-
110
-
-
0025850965
-
Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome
-
M.R. Nelson, G.M. Connolly, D.A. Hawkins, and B.G. Gazzard Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome Am J Gastroenterol 86 1991 876 881
-
(1991)
Am J Gastroenterol
, vol.86
, pp. 876-881
-
-
Nelson, M.R.1
Connolly, G.M.2
Hawkins, D.A.3
Gazzard, B.G.4
-
111
-
-
0025060795
-
Treatment of acquired immune deficiency syndrome (AIDS)-related pneumonitis with foscarnet: A double-blind placebo controlled study
-
M. Youle, A. Chanas, and B. Gazzard Treatment of acquired immune deficiency syndrome (AIDS)-related pneumonitis with foscarnet: a double-blind placebo controlled study J Infect 20 1990 41 50
-
(1990)
J Infect
, vol.20
, pp. 41-50
-
-
Youle, M.1
Chanas, A.2
Gazzard, B.3
-
112
-
-
0025850842
-
Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection
-
S. Safrin, T.G. Berger, and I. Gilson Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection Ann Intern Med 115 1991 19 21
-
(1991)
Ann Intern Med
, vol.115
, pp. 19-21
-
-
Safrin, S.1
Berger, T.G.2
Gilson, I.3
-
113
-
-
0025896084
-
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome
-
S. Safrin, C. Crumpacker, and P. Chatis A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome N Engl J Med 325 1991 551 555
-
(1991)
N Engl J Med
, vol.325
, pp. 551-555
-
-
Safrin, S.1
Crumpacker, C.2
Chatis, P.3
-
114
-
-
0028118607
-
Foscarnet-resistant herpes simplex virus infection in patients with AIDS
-
S. Safrin, S. Kemmerly, and B. Plotkin Foscarnet-resistant herpes simplex virus infection in patients with AIDS J Infect Dis 169 1994 193 196
-
(1994)
J Infect Dis
, vol.169
, pp. 193-196
-
-
Safrin, S.1
Kemmerly, S.2
Plotkin, B.3
-
115
-
-
0028327303
-
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)
-
R. Snoeck, G. Andrei, and M. Gerard Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) Clin Infect Dis 18 1994 570 578
-
(1994)
Clin Infect Dis
, vol.18
, pp. 570-578
-
-
Snoeck, R.1
Andrei, G.2
Gerard, M.3
-
116
-
-
11944275015
-
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis
-
Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group
-
Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis N Engl J Med 326 1992 213 220
-
(1992)
N Engl J Med
, vol.326
, pp. 213-220
-
-
-
117
-
-
0027381464
-
Susceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990
-
M. Valette, J.P. Allard, M. Aymard, and V. Millet Susceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990 Antimicrob Agents Chemother 37 1993 2239 2240
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 2239-2240
-
-
Valette, M.1
Allard, J.P.2
Aymard, M.3
Millet, V.4
-
118
-
-
0034649709
-
Prevention and treatment of influenza
-
R.B. Couch Prevention and treatment of influenza N Engl J Med 343 2000 1778 1787
-
(2000)
N Engl J Med
, vol.343
, pp. 1778-1787
-
-
Couch, R.B.1
-
119
-
-
0025707394
-
Prophylaxis and treatment of influenza
-
R.G. Douglas Jr Prophylaxis and treatment of influenza N Engl J Med 322 1990 443 450
-
(1990)
N Engl J Med
, vol.322
, pp. 443-450
-
-
Douglas, R.G.1
Jr2
-
120
-
-
0023260541
-
Children with influenza a infection: Treatment with rimantadine
-
C.B. Hall, R. Dolin, and C.L. Gala Children with influenza A infection: treatment with rimantadine Pediatrics 80 1987 275 282
-
(1987)
Pediatrics
, vol.80
, pp. 275-282
-
-
Hall, C.B.1
Dolin, R.2
Gala, C.L.3
-
121
-
-
0026773985
-
Antivirals for the chemoprophylaxis and treatment of influenza
-
L.P. Van Voris, and P.M. Newell Antivirals for the chemoprophylaxis and treatment of influenza Semin Respir Infect 7 1992 61 70
-
(1992)
Semin Respir Infect
, vol.7
, pp. 61-70
-
-
Van Voris, L.P.1
Newell, P.M.2
-
122
-
-
0033991487
-
Prevention and early treatment of influenza in healthy adults
-
V. Demicheli, T. Jefferson, D. Rivetti, and J. Deeks Prevention and early treatment of influenza in healthy adults Vaccine 18 2000 957 1030
-
(2000)
Vaccine
, vol.18
, pp. 957-1030
-
-
Demicheli, V.1
Jefferson, T.2
Rivetti, D.3
Deeks, J.4
-
123
-
-
0002734071
-
Clinical and epidemiologic importance of influenza a viruses resistant to amantadine and rimantadine
-
F.G. Hayden, and R.B. Couch Clinical and epidemiologic importance of influenza A viruses resistant to amantadine and rimantadine Rev Med Virol 2 1992 89 96
-
(1992)
Rev Med Virol
, vol.2
, pp. 89-96
-
-
Hayden, F.G.1
Couch, R.B.2
-
124
-
-
0023807899
-
Clinical pharmacokinetics of amantadine hydrochloride
-
F.Y. Aoki, and D.S. Sitar Clinical pharmacokinetics of amantadine hydrochloride Clin Pharmacokinet 14 1988 35 51
-
(1988)
Clin Pharmacokinet
, vol.14
, pp. 35-51
-
-
Aoki, F.Y.1
Sitar, D.S.2
-
125
-
-
0023880060
-
Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure
-
E.V. Capparelli, R.C. Stevens, M.S. Chow, M. Izard, and R.J. Wills Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure Clin Pharmacol Ther 43 1988 536 541
-
(1988)
Clin Pharmacol Ther
, vol.43
, pp. 536-541
-
-
Capparelli, E.V.1
Stevens, R.C.2
Chow, M.S.3
Izard, M.4
Wills, R.J.5
-
126
-
-
0019475566
-
Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function
-
V.W. Horadam, J.G. Sharp, and J.D. Smilack Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function Ann Intern Med 94 1981 454 458
-
(1981)
Ann Intern Med
, vol.94
, pp. 454-458
-
-
Horadam, V.W.1
Sharp, J.G.2
Smilack, J.D.3
-
127
-
-
0019997609
-
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza a infection
-
R. Dolin, R.C. Reichman, H.P. Madore, R. Maynard, P.N. Linton, and J. Webber-Jones A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection N Engl J Med 307 1982 580 584
-
(1982)
N Engl J Med
, vol.307
, pp. 580-584
-
-
Dolin, R.1
Reichman, R.C.2
Madore, H.P.3
Maynard, R.4
Linton, P.N.5
Webber-Jones, J.6
-
128
-
-
0022608508
-
Effectiveness of rimantadine prophylaxis of children within families
-
R.D. Clover, S.A. Crawford, T.D. Abell, C.N. Ramsey Jr, W.P. Glezen, and R.B. Couch Effectiveness of rimantadine prophylaxis of children within families Am J Dis Child 140 1986 706 709
-
(1986)
Am J Dis Child
, vol.140
, pp. 706-709
-
-
Clover, R.D.1
Crawford, S.A.2
Abell, T.D.3
Ramsey Jr., C.N.4
Glezen, W.P.5
Couch, R.B.6
-
129
-
-
0034089948
-
Current research on influenza and other respiratory viruses: II international symposium
-
F.M. Munoz, G.J. Galasso, and J.M. Gwaltney Jr Current research on influenza and other respiratory viruses: II international symposium Antiviral Res 46 2000 91 124
-
(2000)
Antiviral Res
, vol.46
, pp. 91-124
-
-
Munoz, F.M.1
Galasso, G.J.2
Gwaltney Jr., J.M.3
-
130
-
-
17744412173
-
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. US Oral Neuraminidase Study Group
-
J.J. Treanor, F.G. Hayden, and P.S. Vrooman Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group JAMA 283 2000 1016 1024
-
(2000)
JAMA
, vol.283
, pp. 1016-1024
-
-
Treanor, J.J.1
Hayden, F.G.2
Vrooman, P.S.3
-
131
-
-
0034720503
-
Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group
-
K.G. Nicholson, F.Y. Aoki, and A.D. Osterhaus Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group Lancet 355 2000 1845 1850
-
(2000)
Lancet
, vol.355
, pp. 1845-1850
-
-
Nicholson, K.G.1
Aoki, F.Y.2
Osterhaus, A.D.3
-
132
-
-
0003304192
-
Tolerability and pharmacokinetics of the influenza neuraminidase inhibitor Ro-64-0802 (GS4071) following oral administration of the prodrug Ro-64-0796 (GS4104) to healthy male volunteers
-
Toronto. Abstract #A-123. September 28-October 1
-
Wood N.D., Aitken M., Sharp S., Evison H. Tolerability and pharmacokinetics of the influenza neuraminidase inhibitor Ro-64-0802 (GS4071) following oral administration of the prodrug Ro-64-0796 (GS4104) to healthy male volunteers. Presented at 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto. Abstract #A-123. September 28-October 1, 1997
-
(1997)
37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
-
-
Wood, N.D.1
Aitken, M.2
Sharp, S.3
Evison, H.4
-
134
-
-
4444369826
-
Resistant influenza a viruses in children treated with oseltamivir: Descriptive study
-
M. Kiso, K. Mitamura, and Y. Sakai-Tagawa Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 364 2004 759 765
-
(2004)
Lancet
, vol.364
, pp. 759-765
-
-
Kiso, M.1
Mitamura, K.2
Sakai-Tagawa, Y.3
-
135
-
-
0033532975
-
Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial
-
A.S. Monto, D.P. Robinson, M.L. Herlocher, J.M. Hinson Jr, M.J. Elliott, and A. Crisp Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial JAMA 282 1999 31 35
-
(1999)
JAMA
, vol.282
, pp. 31-35
-
-
Monto, A.S.1
Robinson, D.P.2
Herlocher, M.L.3
Hinson Jr., J.M.4
Elliott, M.J.5
Crisp, A.6
-
136
-
-
0034074146
-
Short-term treatment with zanamivir to prevent influenza: Results of a placebo-controlled study
-
L. Kaiser, D. Henry, N.P. Flack, O. Keene, and F.G. Hayden Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study Clin Infect Dis 30 2000 587 589
-
(2000)
Clin Infect Dis
, vol.30
, pp. 587-589
-
-
Kaiser, L.1
Henry, D.2
Flack, N.P.3
Keene, O.4
Hayden, F.G.5
-
137
-
-
0034597724
-
Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group
-
F.G. Hayden, L.V. Gubareva, and A.S. Monto Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group N Engl J Med 343 2000 1282 1289
-
(2000)
N Engl J Med
, vol.343
, pp. 1282-1289
-
-
Hayden, F.G.1
Gubareva, L.V.2
Monto, A.S.3
-
138
-
-
0343851036
-
Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: A randomized, double-blind, placebo-controlled European study
-
M.J. Makela, K. Pauksens, and T. Rostila Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study J Infect 40 2000 42 48
-
(2000)
J Infect
, vol.40
, pp. 42-48
-
-
Makela, M.J.1
Pauksens, K.2
Rostila, T.3
-
139
-
-
0032512327
-
Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza a and B virus infections
-
MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group
-
MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections Lancet 352 1998 1877 1881
-
(1998)
Lancet
, vol.352
, pp. 1877-1881
-
-
-
140
-
-
0034078730
-
Zanamivir for treatment of symptomatic influenza a and B infection in children five to twelve years of age: A randomized controlled trial
-
J.A. Hedrick, A. Barzilai, and U. Behre Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial Pediatr Infect Dis J 19 2000 410 417
-
(2000)
Pediatr Infect Dis J
, vol.19
, pp. 410-417
-
-
Hedrick, J.A.1
Barzilai, A.2
Behre, U.3
-
141
-
-
0034603350
-
Influenza virus neuraminidase inhibitors
-
L.V. Gubareva, L. Kaiser, and F.G. Hayden Influenza virus neuraminidase inhibitors Lancet 355 2000 827 835
-
(2000)
Lancet
, vol.355
, pp. 827-835
-
-
Gubareva, L.V.1
Kaiser, L.2
Hayden, F.G.3
-
142
-
-
0031724750
-
Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus
-
L.V. Gubareva, M.N. Matrosovich, M.K. Brenner, R.C. Bethell, and R.G. Webster Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus J Infect Dis 178 1998 1257 1262
-
(1998)
J Infect Dis
, vol.178
, pp. 1257-1262
-
-
Gubareva, L.V.1
Matrosovich, M.N.2
Brenner, M.K.3
Bethell, R.C.4
Webster, R.G.5
-
143
-
-
0032999877
-
Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers
-
L.M. Cass, J. Brown, and M. Pickford Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers Clin Pharmacokinet 1 1999 21 31
-
(1999)
Clin Pharmacokinet
, vol.1
, pp. 21-31
-
-
Cass, L.M.1
Brown, J.2
Pickford, M.3
-
144
-
-
0034141234
-
Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir
-
L.M. Cass, K.A. Gunawardena, M.M. Macmahon, and A. Bye Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir Respir Med 94 2000 166 173
-
(2000)
Respir Med
, vol.94
, pp. 166-173
-
-
Cass, L.M.1
Gunawardena, K.A.2
MacMahon, M.M.3
Bye, A.4
-
145
-
-
0022630892
-
Lassa fever: Effective therapy with ribavirin
-
J.B. McCormick, I.J. King, and P.A. Webb Lassa fever: effective therapy with ribavirin N Engl J Med 314 1986 20 26
-
(1986)
N Engl J Med
, vol.314
, pp. 20-26
-
-
McCormick, J.B.1
King, I.J.2
Webb, P.A.3
-
146
-
-
0025094088
-
Lassa fever in the United States: Investigation of a case and new guidelines for management
-
G.P. Holmes, J.B. McCormick, and S.C. Trock Lassa fever in the United States: investigation of a case and new guidelines for management N Engl J Med 323 1990 1120 1123
-
(1990)
N Engl J Med
, vol.323
, pp. 1120-1123
-
-
Holmes, G.P.1
McCormick, J.B.2
Trock, S.C.3
-
147
-
-
0032585237
-
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)
-
T. Poynard, P. Marcellin, and S.S. Lee Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet 352 1998 1426 1432
-
(1998)
Lancet
, vol.352
, pp. 1426-1432
-
-
Poynard, T.1
Marcellin, P.2
Lee, S.S.3
-
148
-
-
0032547938
-
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
-
J.G. McHutchison, S.C. Gordon, and E.R. Schiff Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group N Engl J Med 339 1998 1485 1492
-
(1998)
N Engl J Med
, vol.339
, pp. 1485-1492
-
-
McHutchison, J.G.1
Gordon, S.C.2
Schiff, E.R.3
-
149
-
-
0024672299
-
Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug
-
J.W. Huggins Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug Rev Infect Dis 11 Suppl 1989 S750 S761
-
(1989)
Rev Infect Dis
, vol.11
, Issue.SUPPL.
-
-
Huggins, J.W.1
-
150
-
-
0027469706
-
Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection
-
E. Connor, S. Morrison, J. Lane, J. Oleske, R.L. Sonke, and J. Connor Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection Antimicrob Agents Chemother 37 1993 532 539
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 532-539
-
-
Connor, E.1
Morrison, S.2
Lane, J.3
Oleske, J.4
Sonke, R.L.5
Connor, J.6
-
151
-
-
0023267604
-
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome
-
O.L. Laskin, J.A. Longstreth, and C.C. Hart Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome Clin Pharmacol Ther 41 1987 546 555
-
(1987)
Clin Pharmacol Ther
, vol.41
, pp. 546-555
-
-
Laskin, O.L.1
Longstreth, J.A.2
Hart, C.C.3
-
152
-
-
0023613286
-
A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection
-
L.R. Frankel, C.W. Wilson, and R.R. Demers A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection Crit Care Med 15 1987 1051 1054
-
(1987)
Crit Care Med
, vol.15
, pp. 1051-1054
-
-
Frankel, L.R.1
Wilson, C.W.2
Demers, R.R.3
-
153
-
-
0024290117
-
Assessing exposures of health-care personnel to aerosols of ribavirin-California
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention Assessing exposures of health-care personnel to aerosols of ribavirin-California MMWR Morb Mortal Wkly Rep 37 1988 560 563
-
(1988)
MMWR Morb Mortal Wkly Rep
, vol.37
, pp. 560-563
-
-
-
154
-
-
0023276665
-
Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections
-
W.J. Rodriguez, R.H. Bui, and J.D. Connor Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections Antimicrob Agents Chemother 31 1987 1143 1146
-
(1987)
Antimicrob Agents Chemother
, vol.31
, pp. 1143-1146
-
-
Rodriguez, W.J.1
Bui, R.H.2
Connor, J.D.3
-
155
-
-
0345568484
-
Interferons: Biochemical, cell growth, inhibitory, and immunological effects
-
E.C. Borden, and L.A. Fall Interferons: biochemical, cell growth, inhibitory, and immunological effects Prog Hematol 350 1981 1 64
-
(1981)
Prog Hematol
, vol.350
, pp. 1-64
-
-
Borden, E.C.1
Fall, L.A.2
-
157
-
-
0028938996
-
Current therapeutic approaches to viral hepatitis
-
S.Z. Hirschman Current therapeutic approaches to viral hepatitis Clin Infect Dis 20 1995 741 743
-
(1995)
Clin Infect Dis
, vol.20
, pp. 741-743
-
-
Hirschman, S.Z.1
-
158
-
-
0024368522
-
Treatment of chronic hepatitis C with recombinant interferon alfa: A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group
-
G.L. Davis, L.A. Balart, and E.R. Schiff Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group N Engl J Med 321 1989 1501 1506
-
(1989)
N Engl J Med
, vol.321
, pp. 1501-1506
-
-
Davis, G.L.1
Balart, L.A.2
Schiff, E.R.3
-
159
-
-
0026544302
-
Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha
-
H. Hagiwara, N. Hayashi, and E. Mita Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha Hepatology 15 1992 37 41
-
(1992)
Hepatology
, vol.15
, pp. 37-41
-
-
Hagiwara, H.1
Hayashi, N.2
Mita, E.3
-
160
-
-
0032547944
-
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group
-
G.L. Davis, R. Esteban-Mur, and V. Rustgi Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group N Engl J Med 339 1998 1493 1499
-
(1998)
N Engl J Med
, vol.339
, pp. 1493-1499
-
-
Davis, G.L.1
Esteban-Mur, R.2
Rustgi, V.3
-
161
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
M.W. Fried, M.L. Shiffman, and K.R. Reddy Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
-
162
-
-
0023006899
-
Interferon therapy for condylomata acuminata
-
L.J. Eron, F. Judson, and S. Tucker Interferon therapy for condylomata acuminata N Engl J Med 315 1986 1059 1064
-
(1986)
N Engl J Med
, vol.315
, pp. 1059-1064
-
-
Eron, L.J.1
Judson, F.2
Tucker, S.3
-
163
-
-
0023679775
-
Treatment of recurrent respiratory papillomatosis with human leukocyte interferon: Results of a multicenter randomized clinical trial
-
G.B. Healy, R.D. Gelber, A.L. Trowbridge, K.M. Grundfast, R.J. Ruben, and K.N. Price Treatment of recurrent respiratory papillomatosis with human leukocyte interferon: results of a multicenter randomized clinical trial N Engl J Med 319 1988 401 407
-
(1988)
N Engl J Med
, vol.319
, pp. 401-407
-
-
Healy, G.B.1
Gelber, R.D.2
Trowbridge, A.L.3
Grundfast, K.M.4
Ruben, R.J.5
Price, K.N.6
-
164
-
-
0025739466
-
Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1
-
B.G. Leventhal, H.K. Kashima, and P. Mounts Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1 N Engl J Med 325 1991 613 617
-
(1991)
N Engl J Med
, vol.325
, pp. 613-617
-
-
Leventhal, B.G.1
Kashima, H.K.2
Mounts, P.3
-
167
-
-
0022851315
-
Results of treatment with alpha-interferon in adult-onset laryngeal papillomatosis
-
A.M. Schuurman, and P. Van Den Broek Results of treatment with alpha-interferon in adult-onset laryngeal papillomatosis Clin Otolaryngol Allergy Sci 11 1986 447 453
-
(1986)
Clin Otolaryngol Allergy Sci
, vol.11
, pp. 447-453
-
-
Schuurman, A.M.1
Van Den Broek, P.2
-
168
-
-
0025203837
-
Clinical pharmacokinetics of interferons
-
R.J. Wills Clinical pharmacokinetics of interferons Clin Pharmacokinet 19 1990 390 399
-
(1990)
Clin Pharmacokinet
, vol.19
, pp. 390-399
-
-
Wills, R.J.1
-
169
-
-
0023620205
-
Time course of interferon levels, antiviral state, 2′,5′- oligoadenylate synthetase and side effects in healthy men
-
F.M. Barouki, F.R. Witter, and D.E. Griffin Time course of interferon levels, antiviral state, 2′,5′-oligoadenylate synthetase and side effects in healthy men J Interferon Res 7 1987 29 39
-
(1987)
J Interferon Res
, vol.7
, pp. 29-39
-
-
Barouki, F.M.1
Witter, F.R.2
Griffin, D.E.3
-
171
-
-
0023271906
-
Interferons as mediators of psychiatric morbidity
-
E.M. McDonald, A.H. Mann, and H.C. Thomas Interferons as mediators of psychiatric morbidity Lancet 2 1987 1175 1178
-
(1987)
Lancet
, vol.2
, pp. 1175-1178
-
-
McDonald, E.M.1
Mann, A.H.2
Thomas, H.C.3
-
172
-
-
0027969190
-
Treatment of chronic viral hepatitis with alpha interferon: A consensus conference report
-
CASL Hepatitis Consensus Group
-
CASL Hepatitis Consensus Group Treatment of chronic viral hepatitis with alpha interferon: a consensus conference report Can J Infect Dis 5 1994 107 112
-
(1994)
Can J Infect Dis
, vol.5
, pp. 107-112
-
-
-
173
-
-
0037468421
-
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
-
P. Marcellin, T.T. Chang, and S.G. Lim Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 348 2003 808 816
-
(2003)
N Engl J Med
, vol.348
, pp. 808-816
-
-
Marcellin, P.1
Chang, T.T.2
Lim, S.G.3
-
174
-
-
0033592764
-
Lamivudine as initial treatment for chronic hepatitis B in the United States
-
J.L. Dienstag, E.R. Schiff, and T.L. Wright Lamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 341 1999 1256 1263
-
(1999)
N Engl J Med
, vol.341
, pp. 1256-1263
-
-
Dienstag, J.L.1
Schiff, E.R.2
Wright, T.L.3
-
175
-
-
0032499913
-
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group
-
C.L. Lai, R.N. Chien, and N.W. Leung A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group N Engl J Med 339 1998 61 68
-
(1998)
N Engl J Med
, vol.339
, pp. 61-68
-
-
Lai, C.L.1
Chien, R.N.2
Leung, N.W.3
-
176
-
-
0037344319
-
Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon
-
C. Hartman, D. Berkowitz, and D. Shouval Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon Pediatr Infect Dis J 22 2003 224 229
-
(2003)
Pediatr Infect Dis J
, vol.22
, pp. 224-229
-
-
Hartman, C.1
Berkowitz, D.2
Shouval, D.3
-
177
-
-
0027287973
-
Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells
-
W.Y. Gao, T. Shirasaka, D.G. Johns, S. Broder, and H. Mitsuya Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells J Clin Invest 91 1993 2326 2333
-
(1993)
J Clin Invest
, vol.91
, pp. 2326-2333
-
-
Gao, W.Y.1
Shirasaka, T.2
Johns, D.G.3
Broder, S.4
Mitsuya, H.5
-
178
-
-
0033914469
-
In vivo antagonism with zidovudine plus stavudine combination therapy
-
D.V. Havlir, C. Tierney, and G.H. Friedland In vivo antagonism with zidovudine plus stavudine combination therapy J Infect Dis 182 2000 321 325
-
(2000)
J Infect Dis
, vol.182
, pp. 321-325
-
-
Havlir, D.V.1
Tierney, C.2
Friedland, G.H.3
-
179
-
-
0026579208
-
The HIV-1 protease as a therapeutic target for AIDS
-
C. Debouck The HIV-1 protease as a therapeutic target for AIDS AIDS Res Hum Retroviruses 8 1992 153 164
-
(1992)
AIDS Res Hum Retroviruses
, vol.8
, pp. 153-164
-
-
Debouck, C.1
-
180
-
-
0005241362
-
Active human immunodeficiency virus protease is required for viral infectivity
-
N.E. Kohl, E.A. Emini, and W.A. Schleif Active human immunodeficiency virus protease is required for viral infectivity Proc Natl Acad Sci U S A 85 1988 4686 4690
-
(1988)
Proc Natl Acad Sci U S a
, vol.85
, pp. 4686-4690
-
-
Kohl, N.E.1
Emini, E.A.2
Schleif, W.A.3
|